Saratoga, CA, United States of America

A Peter Roszkowski


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1984

Loading Chart...
1 patent (USPTO):Explore Patents

Title: A Peter Roszkowski: Innovator in Ocular Hypertension Treatment

Introduction

A Peter Roszkowski is a notable inventor based in Saratoga, CA (US). He has made significant contributions to the field of ophthalmology, particularly in the treatment of ocular hypertension. His innovative approach has led to the development of a unique topical treatment that addresses this critical health issue.

Latest Patents

Roszkowski holds a patent for a topical treatment of ocular hypertension. This invention concerns the novel use of certain known thiazoles, particularly acylaminothiazoles and thiazolecarboxamides, as intraocular pressure lowering agents. When administered topically to the eye with increased intraocular pressure, these compounds are effective in decreasing intraocular pressure. They also prevent the development of acute or chronic ocular hypertension, including glaucoma. Furthermore, they inhibit the further deterioration of the eye due to intraocular hypertension and relieve the symptoms of already existing ophthalmic disease. He has 1 patent to his name.

Career Highlights

Roszkowski has worked with Syntex (U.S.A.) Inc., where he has been able to apply his expertise in developing innovative treatments. His work has had a significant impact on the field of eye care, providing new options for patients suffering from ocular hypertension.

Collaborations

One of his notable collaborators is L David Waterbury. Together, they have worked on advancing treatments that address critical health issues in ophthalmology.

Conclusion

A Peter Roszkowski's contributions to the treatment of ocular hypertension highlight his innovative spirit and dedication to improving patient care. His work continues to influence the field of ophthalmology and offers hope for those affected by eye diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…